Recall D-0727-2026

US Class II Ongoing · initiated 2026-07-16

Recalling firm

Fresenius Kabi USA, LLC, IL

Product

Naropin (ropivacaine hydrochloride Injection, USP), 0.5%, 100 mg per 20 mL (5 mg per mL), Twenty-five, 20 mL Single-Dose Vials, Rx only, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-286-23; NDC Vial: 63323-286-05

Reason for recall

Presence of Particulate Matter: Hair was found in products

← All recalls